The STAT3 NH2-terminal domain stabilizes enhanceosome assembly by interacting with the p300 bromodomain.
Signal transducer and activator of transcription 3 (STAT3) is a latent transcription factor mainly activated by the interleukin-6 cytokine family. Previous studies have shown that activated STAT3 recruits p300, a coactivator whose intrinsic histone acetyltransferase activity is essential for transcription. Here we investigated the function of the STAT3 NH(2)-terminal domain and how its interaction with p300 regulates STAT3 signal transduction. In STAT3(-/-) mouse embryonic fibroblasts, a stably expressed NH(2) terminus-deficient STAT3 mutant (STAT3-DeltaN) was unable to efficiently induce either STAT3-mediated reporter activity or endogenous mRNA expression. Chromatin immunoprecipitation assays were performed to determine whether the NH(2)-terminal domain regulates p300 recruitment or stabilizes enhanceosome assembly. Despite equivalent levels of STAT3 binding, cells expressing the STAT3-DeltaN mutant were unable to recruit p300 and RNA polymerase II to the native socs3 promoter as efficiently as those expressing STAT3-full length. We previously reported that the STAT3 NH(2)-terminal domain is acetylated by p300 at Lys-49 and Lys-87. By introducing K49R/K87R mutations, here we found that the acetylation status of the STAT3 NH(2)-terminal domain regulates its interaction with p300. In addition, the STAT3 NH(2)-terminal binding site maps to the p300 bromodomain, a region spanning from amino acids 995 to 1255. Finally a p300 mutant lacking the bromodomain (p300-DeltaB) exhibited a weaker binding to STAT3, and the enhanceosome formation on the socs3 promoter was inhibited when p300-DeltaB was overexpressed. Taken together, our data suggest that the STAT3 NH(2)-terminal domain plays an important role in the interleukin-6 signaling pathway by interacting with the p300 bromodomain, thereby stabilizing enhanceosome assembly.
Hou
Tieying
T
Department of Biochemistry, University of Texas Medical Branch, Galveston, Texas 77555-1060, USA.
Ray
Sutapa
S
Lee
Chang
C
Brasier
Allan R
AR
D019943:Amino Acid Substitution; D000818:Animals; D045744:Cell Line, Tumor; D004622:Embryo, Mammalian / Q000166:cytology / Q000378:metabolism; D005347:Fibroblasts / Q000166:cytology / Q000378:metabolism; D051548:Histone Acetyltransferases / Q000235:genetics / Q000378:metabolism*; D006801:Humans; D015850:Interleukin-6 / Q000235:genetics / Q000378:metabolism; D051379:Mice; D018345:Mice, Knockout; D020125:Mutation, Missense; D011485:Protein Binding / Q000502:physiology; D017434:Protein Structure, Tertiary / Q000502:physiology; D012319:RNA Polymerase II / Q000235:genetics / Q000378:metabolism; D050796:STAT3 Transcription Factor / Q000235:genetics / Q000378:metabolism*; D015398:Signal Transduction / Q000502:physiology*; D014158:Transcription, Genetic / Q000502:physiology*; D050880:p300-CBP Transcription Factors / Q000235:genetics / Q000378:metabolism*
C508600:IL6 protein, human; D015850:Interleukin-6; D050796:STAT3 Transcription Factor; C494086:STAT3 protein, human; C494087:Stat3 protein, mouse; D051548:Histone Acetyltransferases; D050880:p300-CBP Transcription Factors; D012319:RNA Polymerase II
Mol Endocrinol. 2002 Apr;16(4):824-36
11923478
Cell. 1996 Dec 27;87(7):1261-70
8980232
J Biol Chem. 2004 Apr 30;279(18):18998-9007
15010467
Mol Cell. 2005 Mar 18;17(6):761-71
15780933
FEBS Lett. 2006 Oct 30;580(25):5880-4
17027757
J Cell Sci. 2001 Jul;114(Pt 13):2363-73
11559745
Science. 2000 May 26;288(5470):1422-5
10827952
Matrix Biol. 1997 Mar;15(8-9):555-65; discussion 567-8
9138288
J Biol Chem. 1998 Aug 14;273(33):21137-44
9694869
Chem Biol. 1997 Dec;4(12):885-8
9427654
EMBO J. 2000 Nov 15;19(22):6141-9
11080160
EMBO J. 2000 Feb 15;19(4):662-71
10675335
Cell. 1996 Mar 22;84(6):843-51
8601308
Nature. 1996 Jul 25;382(6589):319-24
8684459
Curr Opin Genet Dev. 1999 Apr;9(2):140-7
10322133
Mol Cell Biol. 1999 Mar;19(3):1910-8
10022878
Curr Cardiol Rev. 2008 Aug;4(3):179-92
19936194
Curr Opin Genet Dev. 1999 Apr;9(2):132-9
10322136
Biotechniques. 2005 Nov;39(5):715-25
16315372
Annu Rev Biochem. 1998;67:545-79
9759497
Mol Cell. 2002 Mar;9(3):575-86
11931765
Cell. 1996 Nov 29;87(5):953-9
8945521
Mol Cell. 1998 Oct;2(4):457-67
9809067
Nat Rev Mol Cell Biol. 2002 Sep;3(9):651-62
12209125
Mol Cell Biol. 2001 Jun;21(12):3876-87
11359896
Mol Cell Biochem. 2006 Aug;288(1-2):179-89
16718380
FEBS Lett. 2002 Feb 20;513(1):124-8
11911891
Nucleic Acids Res. 1998 Feb 1;26(3):847-53
9443979
Gastroenterology. 2005 Nov;129(5):1616-32
16285960
J Biol Chem. 2001 Sep 7;276(36):33576-81
11438543
Science. 1996 Aug 9;273(5276):794-7
8670419
Nature. 1999 Jun 3;399(6735):491-6
10365964
Nature. 1996 Sep 26;383(6598):344-7
8848048
Mol Cell. 2000 Apr;5(4):745-51
10882110
Biochem J. 1998 Sep 1;334 ( Pt 2):297-314
9716487
Mol Cell Biol. 1999 Oct;19(10):7138-46
10490649
Science. 1998 Feb 13;279(5353):1048-52
9461439
Genes Dev. 1994 Apr 15;8(8):869-84
7523245
J Biol Chem. 2003 May 2;278(18):15794-9
12600988
Science. 1994 Jun 3;264(5164):1415-21
8197455
Mol Cell Biol. 2001 Aug;21(16):5312-20
11463815
J Immunol. 2007 Mar 1;178(5):2623-9
17312100
Proc Natl Acad Sci U S A. 1991 Nov 15;88(22):10004-8
1946417
Trends Genet. 2004 Jan;20(1):23-32
14698616
Mol Cell Biol. 1998 Sep;18(9):5355-63
9710619
EMBO J. 1996 Oct 15;15(20):5616-26
8896455
Cell. 1994 Mar 11;76(5):821-8
7510216
J Biol Chem. 2007 Dec 21;282(51):37091-102
17956865
Mol Cell Biol. 2000 Dec;20(23):8933-43
11073993
Cell. 1997 Aug 22;90(4):595-606
9288740
Eur J Biochem. 2000 Oct;267(19):5849-57
10998044
Gene. 2000 Mar 7;245(1):1-11
10713439
Proc Natl Acad Sci U S A. 1997 Nov 11;94(23):12331-6
9356449
Proc Natl Acad Sci U S A. 1996 Dec 24;93(26):15092-6
8986769
Biochem J. 2003 Aug 15;374(Pt 1):1-20
12773095
J Biol Chem. 2003 Aug 22;278(34):32471-7
12805384
Proc Natl Acad Sci U S A. 1999 Jun 8;96(12):6964-9
10359822
Mol Cell Biol. 1999 May;19(5):3466-73
10207070
Biochem Biophys Res Commun. 2003 Feb 7;301(2):386-91
12565872
Science. 2005 Jan 14;307(5707):269-73
15653507
Protein Sci. 2003 Feb;12(2):361-5
12538899
Science. 1994 Jan 7;263(5143):89-92
8272872